within Pharmacolibrary.Drugs.ATC.D;

model D09AA13
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D09AA13</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Iodoform (triiodomethane) is an organoiodine compound formerly used as an antiseptic and disinfectant for wounds and ulcers. It was historically used in topical dressings and some dental applications, but is largely obsolete in modern medicine due to the development of more effective and less toxic antiseptics.</p><h4>Pharmacokinetics</h4><p>No relevant pharmacokinetic studies in humans found. Pharmacokinetic parameters are estimated based on physicochemical properties and analogous halogenated hydrocarbons.</p><h4>References</h4><ol><li><p>Tada, M, et al., &amp; Hirota, K (2002). [Consciousness disturbance caused by iodoform absorption in a patient with decubitus ulcer topically treated with iodoform-gauze]. <i>No to shinkei = Brain and nerve</i> 54(12) 1051–1054. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12599520/\">https://pubmed.ncbi.nlm.nih.gov/12599520</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D09AA13;
